33
Participants
Start Date
September 16, 2019
Primary Completion Date
December 20, 2019
Study Completion Date
December 31, 2019
Degarelix 120 MG [Firmagon]
Two doses of degarelix, 240 mg, subcutaneously once, at study start.
Gonal F RFF Pen 900 UNT Per 1.5 ML Pen Injector
Gonal-f 300 IU subcutaneously 3 times per week for 5 weeks.
Testosterone Undecanoate
One dose 1000 mg testosterone once, after 3 weeks.
Reproductive Medicine Center, Malmo
Swedish Cancer Foundation
OTHER
ALF Swedish Government Grant
UNKNOWN
Lund University
OTHER